A broadly protective antibody that targets the flavivirus NS1 proteinNaphak Modhiran, Daniel Watterson, Morgan E. Freney et al.|Science|2021Cited by 124
Preclinical development of a molecular clamp‐stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2Daniel Watterson, Keith J. Chappell, Danushka K. Wijesundara et al.|Clinical & Translational Immunology|2021Cited by 62
Molecular clamp stabilised Spike protein for protection against SARS-CoV-2Daniel Watterson, Keith J. Chappell, Danushka K. Wijesundara et al.|Unknown|2020Cited by 15
A single residue in the yellow fever virus envelope protein modulates virion architecture and antigenicitySumma Bibby, Daniel Watterson, James Jung et al.|Nature Communications|2025Cited by 5
Implications of Dengue Virus Maturation on Vaccine Induced Humoral Immunity in MiceConnor A. P. Scott, Daniel Watterson, Alberto A. Amarilla et al.|Viruses|2021Cited by 3